Please login to the form below

Not currently logged in
Email:
Password:

New healthcare comms agency, POP Health, launches in London

The agency aims to offer a personalised approach to the benefit of both clients and employees

POP Health

Former 90Ten managing director Sabrina Gomersall (pictured) has announced the launch of a new London-based healthcare communications agency, POP Health Communications, founded on the 'Power of Partnerships' with its clients and colleagues.

Gomersall, who is the founding director of the agency, has 20 years of extensive industry experience under her belt and believes that ‘the best work is done when an agency and their client truly click’.

To this end, POP Health aims to take the time to understand not only the business goals of its clients, but also personalities and working styles, and builds its services and processes around this.

Sabrina Gomersall

Moreover, the agency seeks to prioritise its employees as much as it does its clients. "Our industry is founded on the importance of understanding people. And having emerged from an isolating time in the pandemic, we need more meaningful interactions to make our work succeed both in its delivery and its outcome,” said Gomersall.

"We’re seeing a rise in quiet quitting and people looking for more time out, but POP is on a mission to increase the joy and effectiveness of our work through the partnerships we make along the way,” she added.

The services on offer span across all areas of healthcare communications; from disease awareness, patient advocacy, product/corporate, internal communications, and issues management.

Article by
Emily Kimber

6th October 2022

From: Marketing, Healthcare

Share

Tags

Related Hub content

Subscribe to our email news alerts

Featured jobs

PMHub

Add my company
Genesis Research

Latest intelligence

Customers, content and change
By Dominic Tyer...
Report: Reinventing product and portfolio value for the biopharmaceutical industry
Gain practical advice on determining and communicating product and portfolio value, including why, in fast-paced and evolving markets, you need to consider the evidence requirements of a growing network of...
How AI is finally helping rare diseases gain more than just attention
By Neil Thompson...

Quick links